Communication

You have full text access to this OnlineOpen article

On the use and abuse of X in the TNM classification

  1. Frederick L. Greene M.D.1,†,‡,*,
  2. James Brierley M.D.2,
  3. Brian O'Sullivan M.D.2,
  4. Leslie H. Sobin M.D.3,‡,
  5. Christian Wittekind M.D.4

Article first published online: 20 DEC 2004

DOI: 10.1002/cncr.20808

Issue

Cancer

Cancer

Volume 103, Issue 3, pages 647–649, 1 February 2005

Additional Information

How to Cite

Greene, F. L., Brierley, J., O'Sullivan, B., Sobin, L. H. and Wittekind, C. (2005), On the use and abuse of X in the TNM classification. Cancer, 103: 647–649. doi: 10.1002/cncr.20808

Author Information

  1. 1

    Department of Surgery, Carolinas Medical Center, Charlotte, North Carolina

  2. 2

    Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada

  3. 3

    Department of Hepatic and Gastrointestinal Pathology, Armed Forces Institute of Pathology, Washington, DC

  4. 4

    Institute of Pathology, University of Leipzig, Leipzig, Germany

  1. †

    Fax: (704) 355-5619

  2. ‡

    Frederick L. Green is Chairman of the American Joint Committee on Cancer, and Leslie H. Sobin is Chairman of the International Union Against Cancer TNM Committee.

*Department of Surgery, Carolinas Medical Center, Charlotte, NC 28232

Publication History

  1. Issue published online: 20 JAN 2005
  2. Article first published online: 20 DEC 2004
  3. Manuscript Revised: 14 OCT 2004
  4. Manuscript Accepted: 14 OCT 2004
  5. Manuscript Received: 27 SEP 2004

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (48K)

REFERENCES

  • 1
    Hutter RVP. At last—worldwide agreement on the staging of cancer. Arch Surg. 1987; 122: 1235–1239.
  • 2
    Sobin LH. TNM: principles, history, and relation to other prognostic factors. Cancer. 2001; 91: 1589–1592.
    Direct Link:
  • 3
    SobinLH, WittekindCL, editors. TNM classification of malignant tumors, 6th ed. New York: John Wiley & Sons, Inc., 2002.
  • 4
    GreeneFL, PageDL, FlemingID, et al., editors. AJCC cancer staging manual, 6th ed. New York: Springer, 2002.
  • 5
    WittekindCL, GreeneFL, HensonDE, et al., editors. TNM supplement. A commentary on uniform use, 3rd ed. New York: John Wiley & Sons, Inc., 2003.
  • 6
    Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of Intergroup Trial INT-0089. J Clin Oncol. 2003; 21: 2912–2919.
  • 7
    Goldstein NS. Lymph node recoveries from 2,427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol. 2002; 26: 179–189.
  • 8
    Klein Kranenbarg E, Hermans J, van Krieken JHJM, van de Velde CJH. Evaluation of the 5th edition of the TNM classification for gastric cancer: improved prognostic value. Br J Cancer. 2001; 84: 64–71.
  • 9
    Sobin LH, Greene FL. TNM classification: clarification of number of regional lymph nodes for pN0. Cancer. 2001; 92: 452.
    Direct Link:
  • 10
    Bree RL, Greene FL, Ralls PW, et al. Suspected liver metastases. American College of Radiology Appropriateness Criteria. Radiology. 2000; 215(Suppl): 213–224.
View Full Article (HTML) Get PDF (48K)